Immune thrombocytopenia purpura(ITP)

Slides:



Advertisements
Similar presentations
Coagulation: Review & Lab techniques
Advertisements

Chapter 12 Disorders of Hemostasis
Haemostasis Prof. K. Sivapalan.
Hemorrhagic diseases. Lesions of the blood vessels Lesions of the blood vessels Abnormal platelets Abnormal platelets Abnormalities in the coagulation.
Bleeding disorders Doc. MUDr. L. Boudová, Ph.D.. Bleeding disorders I. Vessels - increased fragility II. Platelets - deficiency or dysfunction III.Coagulation.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
PLATELETS. PLETELET PHYSIOLOGY Platelets Production: Hematopoietic stem cell  Megakaryoblast  Megakaryocyte  Fragmentation of cytoplasm Platelets.
Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
HEMOSTASIS Hemostasis
Bachelor of Chinese Medicine, The University of Hong Kong Bleeding disorders Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
Disseminated intravascular coagulation (DIC)
Week 7: Fibrinolysis and Thrombophilia Secondary fibrinolysis Secondary fibrinolysis Primary fibrinolysis Primary fibrinolysis Plasminogen Plasminogen.
Blood Course By Dr. Khidir Abdel Galil.
HEMOSTASis Nada Mohamed Ahmed , MD, MT (ASCP)i.
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Hemostasis and Blood Coagulation
FUNCTIONS OF THE COAGULATION SYSTEM ACTIONDESIRED RESULT Rapid formation of mechanically sound clot Stop bleeding quickly Prevent clot formation at non-injured.
HMIM BLOCK 224 PLATELET AND HEMOSTASIS Dr. Zahoor Lecture - 6.
Bleeding Disorders Dr. Farjah H.AlGahtani
HEMOSTASIS Primary hemostasis.
1 HAEMOSTASIS. 2 Definition Haemostasis is a complex sequence of physical and biochemical changes induced by damage to tissues and blood vessels, which.
DIC Dr MB Dhlamini Department of Molecular Medicine and Haematology WITS University.
Disseminated intravascular coagulation
MLAB 1227: Coagulation Keri Brophy-Martinez Coagulation Disorders: Secondary Hemostasis Part Two.
DIC disseminated intravascular coagulation DIC is characterized by widespread coagulation and bleeding in the vascular compartment. DIC begins with massive.
Disseminated Intravascular Coagulation (DIC) 【 Change of basic pathology 】 【 Change of basic pathology 】 Key change Key change This fine homeostatic.
Hemostasis & blood coagulation Dr. Wasif Haq. Hemostasis Hemostasis: prevention of blood loss. Is hemostasis same as homeostasis?
Disseminated Intravascular Coagulation. XIIa Coagulation cascade IIa Intrinsic system (surface contact ) XII XI XIa Tissue factor IX IXa VIIa VII VIIIVIIIa.
Fibrinolysis and Hyperfibrinolysis TEG Analysis
Acquired haemolytic anaemias
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
Hemostatic process 1- Vascular Consrriction 2- Platelet plug formation 3- Fibrin formation ( Coagulation ) 4- Fibrinolysis.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 26 Disorders of Hemostasis.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Coagulation tests CBC- complete blood count
Plasma and plasma components in the management of disseminated intravascular coagulation Marcel Levi* Academic Medical Center, University of Amsterdam,
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
Haemostasis describes the normal process of blood clotting. It takes place via a series of complex, tightly regulated interactions involving cellular.
Platelets (Thrombocytes)
Bleeding disorders due to vascular & platelets abnormalities
Blood Made of Average person 4-6L 7.4 pH, acidosis if falls below 7.35
Disseminated Intravascular Coagulation
HAEMOSTASIS AND THROMBOSIS Regulation of coagulation
MLAB Hematology Fall 2007 Keri Brophy-Martinez
Inherited disorders of platelet function
Haematology.
2nd Year Medicine- Blood Module May 2008
IMMUNE HEMOLYSIS Definition : red cell life span is shortened because abnormalities in the components of the immune system are specifically directed against.
Acquired coagulation disorders
Platelets disorders.
Constituents of the blood: Platelets and plasma
Disseminated Intravascular Coagulation
platelet function:    1- Adhesion — the deposition of platelets on the .
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Disseminated intravascular coagulation (DIC) + Thrombotic microangiopathies (TTP+HUS) Ali Al Khader, M.D. Faculty of Medicine Al-Balqa’ Applied University.
Disseminated Intravascular Coagulation
The Fascinating World of Haemostasis and Thrombosis
Inherited disorders of platelet function
Drugs Affecting Blood.
Approach to Haemolysis
Approach to Bleeding Disorders DR
THROMBOSIS.
Bleeding Disorders DR. FATMA AL-QAHTANI
Dr. Ahmed Hassaneen Coagulation disorders.
Hemostasis and Coagulation
Presentation transcript:

Immune thrombocytopenia purpura(ITP)

Immune thrombocytopenia purpura(ITP) 1- Chronic ITP: This is relatively common disorder ,with highest incidence in women 15-50 y ,it is commonest cause of thrombocytopenia without anemia or neutropenia ,it is usually idiopathic but may be seen in association with other disorders e.g. SLE ,HIV infection, CLL, Hodgkin's disease or autoimmune hemolytic anemia.

Pathogenesis: Platelets sensitization with autoantibody usually IgG result in their premature removal from circulation by cells of RE system. The normal life span of platelets is 7-10 days but in ITP is reduced to few hours. Lightly sensitized platelets mainly destroyed by macrophages in spleen but heavily sensitized platelets or platelets coated with complement as well as IgG mainly destroyed throughout RE system mainly in liver.

Diagnosis: 1- Platelets count 10-50×109/L, Hb & WBC are normal. 2- Blood film shows reduced platelets number & often large. 3-BM shows normal or increased number of megakaryocytes. 4- Sensitive tests to demonstrate anti platelets IgG either alone or with complement or IgM on platelets surface or in serum 5-Antinuclear factor is present in serum of patient with SLE 6-Direct antiglobulin test is positive in case with associated autoimmune hemolytic anemia.

2- Acute ITP: Is most common in children , the mechanism is not well established . In 75% of patients ,the thrombocytopenia & bleeding follow vaccination or/& infection e.g. measles, chicken pox or infectious mononucleosis ,and allergic reaction with immune complex formation & complement deposition on platelet is suspected. Spontaneous remission is usual, but in 5-10% of cases the disease becomes chronic.

Hereditary disorders Thrombasthenia (Glanzmann's disease) This autosomal recessive disorder leads to failure of primary platelet aggregation because of a deficiency of membrane GPIIb Bernard-Soulier syndrome In this disease the platelets are larger than normal and there is a deficiency of GPIb. There is defective binding to VWF, defective adherence to exposed subendothelial connective tissues

Storage pool diseases In the rare grey platelet syndrome, the platelets are larger than normal and there is a virtual absence of alpha granules with deficiency of their proteins. In the more common beta storage pool disease there is a deficiency of dense granules.

Acquired disorders Antiplatelet drugs Aspirin therapy is the most common cause of defective platelet function. It produces an abnormal bleeding time Hyperglobulinaemia associated with multiple myeloma or Waldenstrom's disease may cause interference with platelet adherence, release and aggregation. Myeloproliferative and myelodysplastic Disorders Intrinsic abnormalities of platelet function occur

UraemiaThis is associated with various abnormalities of platelet function. Heparin, dextrans, alcohol and radiographic contrast agents may also cause defective function

DIC (disseminated intravascular coagulation). Wide spread intravascular deposition of fibrin with consumption of coagulation factors & platelets occur as consequence of many disorders which release procoagulant material into the circulation or cause wide spread endothelial damage or platelets aggregation. It may be associated with fulminant hemorrhagic syndrome or run less severe & more chronic course.

Causes of DIC: 1-Infections: gram negative & meningococcal septicaemia, septic abortion &clostridium welchii septiacemia, severe falciparum malaria, & viral infection. 2-Malignancy: widespread mucin-secreating adenocarcinoma& promylocytic leukaemia. 3- Obstetric complication: amniotic fluid embolism, premature separation of placenta, eclampcia& retained placenta 4-Hypersensetivity reactions: Anaphylaxis & incompatible blood transfusion 5- Widespread tissue damage: following surgery or trauma. 6-other: liver failure, snake venoms severe burns, hypothermia, heat stroke, acute hypoxia &vascular malformation.

Pathogenesis: 1-DIC may be triggered by entry of procoagulant material into circulation 2-DIC may be initiated by widespread endothelial damage & collagen exposure. 3-Widespread intravascular platelets aggregation may also precipitate DIC. 4-intravascular thrombin formation produce large amount of circulating fibrin monomers which form complex with available fibrinogen. 5- Intense fibrinolysis is stimulated by thrombi on vascular walls & release of split products interferes with fibrin polymerization 6- The combined action of thrombin & plastin normally causes depletion of fibrinogen, prothrombin, factor V & VIII. 7- Intravascular thrombin also causes widespread platelets aggregation, release & deposition leading to consumption of platelets.

Lab. Findings: Tests of haemostasis: 1-The platelets count is low 2-Fibrinogen screening tests or assay indicate deficiency. 3- The thrombin time is prolonged 4-high levels of fibrinogen & fibrin degradation products are seen in serum & urine. 5- Test for the fibrin-monomer complex is positive 6- The prothrombin time & APTT are prolonged. 7-Factor V &VIII activities are reduced

Blood film: There is hemolytic anemia with red cells fragmentation due to their passage through fibrin strands in small vessels.